The Trump administration has accused the Chinese government of “unfairly” using venture capital to acquire cutting-edge technologies being developed in the United States, including biotechnology and artificial intelligence.
In a report released this week, the U.S. trade representative said China had doubled down on its “unreasonable actions” since an investigation in March that alleged China is stealing American trade secrets and tilting the playing field in its favor with suspect licensing and investment practices.
About the Author Reprints
